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ABSTRACT
Objective: The main objective of the present research work was to formulate and evaluate gel loaded with microspheres of apremilast to increase 
bioavailability and to reduce the dosing frequency and to improve patient compliance.
Methods: Gel loaded with microspheres of apremilast was prepared by solvent evaporation method by taking different ratios of polymers. Ethyl 
cellulose as a polymer, dichloromethane solvent is used as drug solubility, polyvinyl alcohol as a surfactant, and sodium alginate is used as gelling 
agent. Prepared gel loaded with microspheres was evaluated for drug interactions by Fourier transform infrared (FTIR), differential scanning 
calorimetry studies, and surface morphology by scanning electron microscopy (SEM), to select effective one among all formulations. The prepared 
formulations (F1–F6) were evaluated for pre-formulation studies, spreadability, viscosity, pH measurement, gel strength, homogeneity, drug content, 
in vitro diffusion studies, drug kinetics, and finally for stability studies.
Results: Differential scanning calorimeter studies confirmed that there is no drug interaction between drug and excipients. FTIR spectroscopy studies 
confirmed that there is compatibility between drug and excipients. Regular and spherical shape particles with smooth surface were observed in 
the SEM photographs. The optimized gel loaded with microspheres of F4 formulation (drug: polymer in 1:4 ratio) is more effective compared to all 
formulations. The prepared gel showed acceptable physical properties such as spreadability (5.86±0.54 g.cm/s), viscosity (568 cps), pH (6.33±0.55), 
gel strength (38 s) and drug content (90.00±0.71%). In vitro diffusion studies have shown 80.1±1.92% drug release in 10 h. Drug kinetics follows zero 
order kinetics and n value was found to be 0.721. Stability studies were done for 3 months.
Conclusion: All the results show that the gel loaded with microspheres of apremilast can be effectively used for the treatment of psoriasis and 
psoriatic arthritis.
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INTRODUCTION
Psoriasis and psoriatic arthritis are a chronic skin disease of 
autoimmune system that is identified as patches of abnormal skin [1]. 
Apremilast inhibits the enzyme phosphodiesterase 4 which leads to 
spontaneous inhibition of tumor necrosis factor-alpha production from 
human rheumatoid synovial cell [2]. In addition, the application of oral 
drug delivery has numerous problems such as abdominal pains, upper 
respiratory, nasopharyngitis, and depression that often ends in lack 
of patient compliance [3]. Drugs that are not soluble in water can be 
entrapped in microsponge pores, which are extremely small, thus the 
drug functions as microscopic particles, producing a greater surface 
area and increasing the rate of solubilization [4].
Microspheres defined as solid spherical particles, approximately the 
size ranges from 1 to 1000 μm containing dispersed drug molecules 
either in solution or crystalline forms [5]. They are shallow spherical, 
free-flowing powders consisting of proteins polymers or synthetic 
polymers which are biodegradable in nature [6].
Microspheres are a polymeric matrix system which contains the drug 
in a state of uniform distribution throughout the matrix. Polymers 
such as ethyl cellulose are used for the preparation of matrix-type 
microspheres of water-soluble drugs to control the dissolution rate 
of drugs from the dosage forms [7]. Transdermal gels are a semisolid 
system, they prepared from a liquid which is thickened with other 
ingredients. The drug release through skin membrane and preparation 
of gelling agent sodium alginate is used [8]. The present work is to 
increase bioavailability and reduce the dosing frequency and improve 
patient compliance by designing formulation and evaluation of gel 




Apremilast (Gift sample by Alembic Pharmaceuticals Limited, Vadodara, 
India), It is a water-insoluble drug, so it is chosen as a main drug. Ethyl 
cellulose was used as a polymer (Qualikems Fine Chem Pvt., Ltd.). 
Polyvinyl alcohol is used as a surfactant (Qualikems Fine Chem Pvt., 
Ltd., Vadodara, India). Sodium alginate is used as a gelling agent (NR 
Chem, Mumbai). Dichloromethane is used as drug solubility (Qualikems 
Fine Chem Pvt., Ltd.).
Methods
Formulation of gel loaded with microsphere
Preparation of apremilast microspheres
Using solvent evaporation method, apremilast microspheres were 
prepared. By taking ethyl cellulose as a polymer and solution of 
dichloromethane solvent were used with combination to get perfect 
dissolution of drug in it. Initially, formulation was developed to select 
a best-suited solvent system for selected solvent evaporation method. 
The drug and polymer ratio concentration was remained constant for 
the formulation F1–F6. Desired quantity of ethyl cellulose polymer was 
dissolved in 10 ml dichloromethane solvent. Calculated drug was added 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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to this polymer solution and mixed uniformly using ultrasonication 
water bath for 5 min. Take 0.5% w/v polyvinyl alcohol in another 
beaker heat it for 60°C for 10–15 min. The resultant mixture was 
mixed thoroughly. In this, polyvinyl alcohol solution add dropwise of 
drug + polymer + dichloromethane solvent by continuous stirring at 
300–1000 rpm for 3 h to produce microspheres. Formed microspheres 
were collected by vacuum filtration and dried at room temperature for 
24 h to get free-flowing microspheres (Fig. 1).
Preparation of gel loaded with microspheres
Take 2% w/v sodium alginate and water was added by continuous 
stirring at 1000–1200 rpm and the resultant mixture was mixed 
thoroughly. In this sodium alginate gel add prepared microspheres, they 
should get uniformly dispersed in gel by magnetic stirring for 10 min to 
form gel loaded with microspheres (Fig. 2) [4]. The detailed composition 
of various formulations was prepared and mentioned in Table 1.
EVALUATION TESTS
Evaluation of microspheres
Scanning electron microscopy (SEM)
SEM was used to determine the particle size distribution, surface 
topography, and texture. The microspheres were viewed at accelerated 
voltage of 1000 volts.
Differential scanning calorimetry (DSC)
The thermogram of pure drug, pure polymer, and drug-loaded 
microspheres was obtained at a scanning rate of 20°C/min over a 
temperature vary of 154.1°C.
Evaluation of gel loaded with microspheres
Viscosity of the gel was determined using Brookfield viscometer 
evaluation of gel is determined by calculating gel strength, homogeneity, 
and pH [9].
Spreadability
About 1 g of gel was placed at the center of glass slide. Next, the weight 
of 1000 g was carefully applied on the upper side of the slide after 5 min. 
Weight of 150 g is gradually added to pan to the upper slide by means of 
string and hook. Note the time at which the upper slide moves little over 
the lower slide and this was taken as a measurement of spreadability 
can be calculated using formula:
S=ML/T.
Drug and polymer interaction study Fourier transform infrared 
(FTIR)
FTIR spectroscopy was performed on FTIR spectrophotometer and it is 
used to study and find out whether there are any interactions between 
the drug and excipients used in the formulation.
Drug content
Weighed quantity (10 mg) of developed gel loaded with microspheres 
was taken and dissolved in 100 ml methanol. Then, the solution was 
kept in an ultrasonication water bath for 5 min to get a uniform mixture. 
Later, absorbance of prepared solution was measured using ultraviolet-
visible (UV) spectrophotometer at 263 nm [10].
In vitro diffusion study
Using modified apparatus of cellophane membrane was used to study 
the in vitro release of microspheres loaded gel formulation. Before 
using cellophane membrane, it should be soaked in a dissolution 
medium and it is tied to one end of a glass cylinder (open at both the 
ends). The dissolution medium was filled with a phosphate buffer 
(pH 6.8). 10 mg of drug-containing gel loaded with microspheres was 
placed into this assembly. The cylinder was connected to a stand and 
suspended in dissolution medium. The dissolution medium was kept at 
room temperature and stirred at 100 rpm using Teflon-coated magnetic 
bead. The test was taken place for about 10 h. For every hour, 5 ml was 
withdrawn with aliquots, and it is going to be filled with equal volume 
of receptor medium. The sample was diluted and measured using UV 
spectrophotometer at 263 nm.
In vitro drug kinetic studies
To analyze the mechanism of drug release kinetics was obtained by 
zero order, first order, Higuchi’s, and Korsmeyer–Peppas model. If 
Table 1: Composition of formulations from F1 to F6
Formulations code Drug (Apremilast) (mg) Polymer (ethyl cellulose) (mg) DCM solvent Polyvinyl alcohol (%) Sodium alginate (%)






Fig 1: Apremilast microspheres
Fig 2: Gel loaded with microspheres of apremilast
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n=0.45, the release is by Fickian diffusion, and if n=0.89, the release is 
zero order, and if 0.45<n<0.89, then the release is through non-Fickian 
diffusion or anomalous diffusion.
Stability studies
Selected drug loading formulations were subjected to stability study. 
Formulations were stored at glass container for 3 months at 30°C and at 
75% relative humidity (RH). The F4 formulation was evaluated for 3 months 
and sample stability was carried out for visual inspection, stability was 
evaluated by the measurement of pH, spreadability, and drug content [11].
RESULTS AND DISCUSSION
FTIR spectrum of pure apremilast and with excipient
FTIR spectra for the formulation and pure drug are shown in 
Fig. 3 and 4. The spectrum of pure drug and formulation F4 presented 
characteristic peaks at 3425 cm−1 and 3442.87 cm−1 (amine or amide 
N-H), 1621 cm−1 and 1631.75 cm−1 (alkene C=C), 1340 cm−1 and 
1413.61 cm−1 (alkane –C-H), 1095 cm−1 and 1095.89 cm−1 (C-OH), and 
1044 cm−1 and 1034.17 cm−1 (ester C-O). This indicates that the drug 
was compatible with excipients.
Evaluation of microspheres
SEM
SEM photograph of F4 formulation of 1:4 ratio is shown in Fig. 6. 
Surface smoothness of apremilast microspheres was discrete, large size 
and showed less aggregation with spherical and uniform free flowing 
which was confirmed by SEM. At lower concentration, F2 formulation 
of (1:2 ratio) surface was rough (Fig. 5) [12].
DSC
The pure apremilast showed a sharp endothermic peak at 156.1°C 
and some similar changes occur in endothermic peak were observed 
at similar temperature in prepared formulation at 154.2°C. Thus, it is 
concluded that there is no drug excipients interaction (Fig. 7).
Evaluation of gel-loaded microspheres
Viscosity studies
The viscosity of F1, F2, F3, F4, F5, and F6 formulations shows that the 
concentration of polymer increases, viscosity of gel formulation also 
Fig. 3: Fourier transform infrared spectra of apremilast
Fig. 4: Fourier transform infrared spectra of optimized formulation
Fig5: Scanning electron microscopy photographs of F4 
formulation
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increases. However, at the higher concentration of polymer may affect 
the spreadability of gel formulation. From the results, it was concluded 
that the formulation F4 showed maximum viscosity, that is, 568 cps and 
formulation F1 showed minimum viscosity, that is, 100 cps (Fig. 8). The 
value of viscosity is shown in Table 2.
Gel strength
Gel strength is important because strong gels will support a much 
higher pressure than weak gels before they are washed out of the 
targeted site. It is calculated in time (s) and found within the range of 
15–38 s. The values of gel strength are shown in Table 2.
Homogeneity
All developed gels showed good homogeneity with the absence of lumps. 
The developed preparations were much clear and transparent [13]. The 
results are shown in Table 2.
Fig. 6: Differential scanning calorimetry of apremilast
Fig 7: Differential scanning calorimetry of gel loaded with 
microspheres of apremilast
Table 2: Viscosity, gel strength, homogeneity, and pH of formulation code of F1–F6
Formulation code Viscosity (cps) Gel strength (s) Homogeneity pH *
F1 100 15 Satisfactory 5.53±0.41
F2 190 22 Good 6.23±0.73
F3 300 35 Good 6.16±0.87
F4 568 38 Excellent 6.33±0.55
F5 360 26 Satisfactory 7.00±0.2
F6 240 32 Good 7.20±0.3
*Mean±SD, n=3. SD: Standard deviation
Fig 8: Viscosity of gel loaded with microspheres of apremilast
Fig. 9: Spreadability of gel loaded with microsphere of apremilast
Fig. 10: In vitro percentage drug release of formulation code of 
F1–F3
Fig. 11: In vitro percentage drug release of formulation code of 
F4–F6
Fig. 12: Graphical presentation of zero-order release kinetics
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Measurement of pH
The pH values of all formulations of gel were in a range of 5.53±0.41 
to 7.20±0.3 which is well within the limits of skin pH, that is, 5.6–7.5. 
Hence, it was concluded that all formulations could not produce any 
local irritation to the skin [14]. The results are shown in Table 2.
Spreadability
The spreadability of gel loaded with microspheres was found to be 
0.7±0.47g cm/s–5.86±0.54 g.cm/s. The result is shown in Table 3 
compared to all formulations F4 formulation indicated a good 
spreadability (Fig. 9).
Drug content
The percentage drug content of all prepared gel loaded with 
microspheres formulations is in the range of 77.02±0.19–90.00±0.71. 
The result is shown in Table 3 compared to all formulations F4 
formulation indicated a good drug content.
In vitro diffusion studies
The diffusion studies were carried out using cellophane membrane 
using phosphate buffer (pH 6.8) as a dissolution medium for 10 h. The 
drug release was increased with decreased due to increase in polymer 
concentration (Table 4) [15]. Compared all formulations F4 formulation 
shows best drug release at 10 h (Figs 10 and 11).
Drug release kinetics of in vitro studies
In vitro drug release kinetics data of F4 formulation were subjected to 
release kinetic study according to zero order, first order, Higuchi model, 
and Korsmeyer–Peppas equation to find out the mechanism of drug 
release [16].
It was found that the F4 formulation follows the zero-order kinetics 
and it shows the best correlation by the Higuchi model proving that 
the release is by diffusion mechanism. Moreover, Korsmeyer–Peppas 
model showed anomalous mode of drug release (Tables 5 and 6). n 
value of Korsmeyer–Peppas model for gel loaded with microspheres of 
apremilast formulation is 0.721 (Figs. 12-15).
Stability studies
The stability studies were carried out for 3 months at 30°C and at 
75% RH. No major changes occur in following parameters such as 
measurement of pH, spreadability, and drug content. Thus, it can be 
concluded that the F4 formulation is in stable condition (Table 7).
The application of the oral drug delivery of apremilast has numerous 
problems such as lesser bioavailability, diarrhea, vomiting, loss 
of appetite, and headache [2]. To overcome these problems, it is 
attempted to formulate gel loaded with microspheres of apremilast 
using solvent evaporation method. F1–F6 formulation was prepared 
using different concentration of polymer ratio. Apremilast in 1:4 
(F4) ratio produces better spreadability, viscosity, and gel strength 
Fig. 13: Graphical presentation of first-order kinetics
Fig. 14: Graphical presentation of Higuchi model
Fig. 15: Graphical presentation of Korsmeyer–Peppas model













*Mean±SD, n=3. SD: Standard deviation
Table 4: Percent drug release of all formulation codes of F1–F6
Time (h) F1 F2 F3 F4 F5 F6
0 0 0 0 0 0 0
1 9.9±0.19 11.7±0.21 13.5±0.34 16.2±0.55 14.4±0.25 12.6±0.20
2 17.1±0.23 18.9±0.28 20.7±0.39 22.5±0.72 21.6±0.33 19.8±0.26
3 24.3±0.28 26.1±0.32 29.7±0.48 32.4±0.89 31.5±0.42 27.0±0.31
4 33.3±0.32 35.1±0.39 38.7±0.53 41.4±0.96 37.8±0.48 36.9±0.35
5 35.1±0.36 44.1±0.45 46.8±1.02 48.6±1.25 47.7±0.66 45.9±0.40
6 46.8±0.45 49.5±0.50 51.3±1.24 53.1±1.38 48.6±0.78 50.4±0.49
7 54.0±0.50 55.8±0.57 57.6±1.35 60.3±1.44 59.4±0.92 56.7±0.55
8 61.2±0.56 63.0±0.64 65.7±1.44 67.5±1.52 66.6±0.98 64.8±0.61
9 65.7±0.70 69.3±0.72 71.1±1.56 73.8±1.68 72.0±1.21 70.2±0.68
10 71.1±0.79 75.6±0.85 77.4±1.69 80.1±1.92 78.3±1.30 76.5±0.83
*Mean±SD, n=3. SD: Standard deviation
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when compared to other formulations. SEM studies of prepared 
microspheres were within the range of 1–1000 µm. There is no 
drug excipients interaction in FTIR and DSC. The formulation of F4 
showed good consistency and homogeneity, the pH is within the limit 
of skin so no skin irritation. The percent drug content was found to 
be 90.00±0.71%. The in vitro percentage drug release was found to 
be 80.1±1.92% in 10 h and drug kinetics follows zero-order kinetics, 
and moreover, Korsmeyer–Peppas model showed anomalous mode of 
drug release, in F4 formulation. Stability studies were conducted for 
a period of 3 months.
CONCLUSION
Gel loaded with microspheres of apremilast was prepared with aim to 
deliver the drug which passes through transdermal route as it provides 
quick onset of action when compared to oral route. This gel loaded with 
microspheres of apremilast was successfully prepared using solvent 
evaporation method by taking different concentration of polymer ratio.
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